Shanghai Pharmaceutical Company Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Pharmaceutical Company Limited with three other
companies in this sector in China:
China National Accord Medicines Corporation Limited
sales of 25.99 billion Chinese Renmimbi [US$3.84 billion]
of which 93%
was Pharmaceutical Sales),
Huadong Medicine Company Limited
(21.73 billion Chinese Renmimbi [US$3.21 billion]
of which 80%
was Commerce), and
Jointown Pharmaceutical Group Co Ltd
(49.58 billion Chinese Renmimbi [US$7.33 billion]
of which 97%
During the year ended December of 2015, sales at
Shanghai Pharmaceutical Company Limited were 105.52 billion Chinese Renmimbi (US$15.59 billion).
increase of 14.2%
versus 2014, when the company's sales were 92.40 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shanghai Pharmaceutical Company Limited
(and since 2010, sales have increased a total of 182%).
Sales of Retail Segment saw an increase
that was more than double the company's growth rate: sales were up
43.7% in 2015, from
3.31 billion Chinese Renmimbi to 4.76 billion Chinese Renmimbi.